Harp to present on ADCs at the PDA annual meeting

Ashley Harp, ADC subject matter expert, is set to present at the upcoming PDA Annual Meeting in Long Beach California on March 25.

Advancements and Challenges in Antibody-Drug Conjugate Manufacturing

Monday, March 25th
15:30 – 15:50

This presentation provides insights into Antibody-Drug Conjugates (ADCs), addressing manufacturing challenges, facility implications, regulatory considerations, and the future of ADCs. Ashley Harp will highlight the growing focus on sustainability, adoption of advanced purification technologies, and the need for enhanced safety protocols due to increasing cytotoxicity. Potential strategies to reduce solvent use, such as continuous chromatography technology, are discussed, along with the imperative for improved containment measures as ADC toxicity rises. Innovative purification methods in the R&D space like membrane chromatography and filtration are also explored for potential in minimizing waste and optimizing processing. In summary, the presentation offers a comprehensive exploration of the ADC market. Ashley will highlight case studies and industry data to help the audience understand the intricacies associated with this industry and offers a path forward, promoting safer, more sustainable, and potent therapies.

To learn more about the event, click here.